CC7 Pneumonia, pneumonitis, or progressive disease during immunotherapy in lung cancer?

Challenging clinical cases
Chairs: A. Rittmeyer (Immenhausen, Germany)
Aims: Access educational materials here
Immunotherapy in advanced NSCLC is advancing to a new standard of care and is currently being administered more frequently and to a broader patient population. The aim of this session is to present three different cases of lung cancer lesions that were treated with immunotherapy and exhibited radiological progression that was due to pneumonia, pneumonitis, or tumour disease progression.

Case 1: Is it pneumonia, pneumonitis, or progressive disease? B. Grigoriu (Bruxelles, Belgium)
Case 2: Is it pneumonia, pneumonitis, or progressive disease? D. Jovanovic (Beograd, Republic of Serbia)
Case 3: It is … K. Bostantzoglou (Athens, Greece)